SCHEMBL7977149

SCHEMBL7977149

CCOc1nc2c(O)cccc2n1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.46
LMNA P02545 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
MAPT P10636 4/20 0.37
TSHR P16473 3/20 0.37
HPGD P15428 2/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11923729 0.83 TLR8 (0.44) TLR8LMNAL3MBTL1MEN1KMT2A
SCHEMBL7011080 0.82 ACHE (0.42) TLR8LMNAMEN1KMT2ANPC1
SCHEMBL11923723 0.81 SMN1; SMN2 (0.40) LMNAL3MBTL1MEN1KMT2ANPC1
SCHEMBL7975692 0.76 TLR8 (0.49) TLR8LMNAMEN1KMT2ANPC1
SCHEMBL7981497 0.75 HTR1A (0.47) TLR8LMNAL3MBTL1MEN1KMT2A
SCHEMBL6654439 0.74 TLR8 (0.46) TLR8LMNAMEN1KMT2ANPC1
SCHEMBL13543523 0.73 RAB9A (0.54) LMNAL3MBTL1MEN1KMT2ANPC1
SCHEMBL3194071 0.73 CYP1A2 (0.49) TLR8LMNAMEN1KMT2ANPC1
SCHEMBL7965261 0.72 TLR8 (0.43) TLR8LMNAL3MBTL1MEN1KMT2A
SCHEMBL7978871 0.72 AKT1 (0.42) TLR8L3MBTL1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed